Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2018-12-01 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: WINGERSHEIM LES QUATRE BANS (67170), Bas-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LES QUATRE BANS : revenue, balance sheet and financial ratios
PHARMACIE LES QUATRE BANS is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in WINGERSHEIM LES QUATRE BANS (67170),
this company of category PME
shows in 2023 a net income positive of 123 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LES QUATRE BANS (SIREN 845389691)
Indicator
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
123 385 €
229 896 €
112 272 €
115 195 €
-6 882 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE LES QUATRE BANS generates positive net income of 123 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
123 385 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 403%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 18%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
403.262%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
17.672%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE LES QUATRE BANS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
Debt ratio
-26300.935
1363.329
648.643
631.084
403.262
Financial autonomy
-0.33
6.031
10.949
11.839
17.672
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
403.262023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average
In 2023, the debt ratio of PHARMACIE LES QUATRE BANS (403.26) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
17.67%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of PHARMACIE LES QUATRE BANS (17.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 190.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
190.002
Liquidity indicators evolution PHARMACIE LES QUATRE BANS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
Liquidity ratio
97.373
129.413
103.829
212.338
190.002
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
190.02023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Good+31 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE LES QUATRE BANS (190.00) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE LES QUATRE BANS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE LES QUATRE BANS is estimated at
1 455 878 €
(range 885 389€ - 2 046 638€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
885k€1455k€2046k€
1 455 878 €Range: 885 389€ - 2 046 638€
NAF 5 année 2023
Valuation method used
Net Income Multiple
123 385 €
×
11.8x
=1 455 878 €
Range: 885 389€ - 2 046 638€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LES QUATRE BANS with other companies in the same sector:
Frequently asked questions about PHARMACIE LES QUATRE BANS
What is the revenue of PHARMACIE LES QUATRE BANS ?
The revenue of PHARMACIE LES QUATRE BANS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE LES QUATRE BANS profitable?
Yes, PHARMACIE LES QUATRE BANS generated a net profit of 123 k€ in 2023.
Where is the headquarters of PHARMACIE LES QUATRE BANS ?
The headquarters of PHARMACIE LES QUATRE BANS is located in WINGERSHEIM LES QUATRE BANS (67170), in the department Bas-Rhin.
Where to find the tax return of PHARMACIE LES QUATRE BANS ?
The tax return of PHARMACIE LES QUATRE BANS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LES QUATRE BANS operate?
PHARMACIE LES QUATRE BANS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart